BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 409490)

  • 1. Prolactin binding to 7,12-dimethylbenz(a)anthracene-induced mammary tumors and liver in diabetic rats.
    Smith RD; Hilf R; Senior AE
    Cancer Res; 1977 Nov; 37(11):4070-4. PubMed ID: 409490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prolactin binding to mammary gland, 7,12-dimethylbenz(a)-anthracene-induced mammary tumors, and liver in rats.
    Smith RD; Hilf R; Senior AE
    Cancer Res; 1976 Oct; 36(10):3726-31. PubMed ID: 821605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolactin binding to R3230AC mammary carcinoma and liver in hormone-treated and diabetic rats.
    Smith RD; Hilf R; Senior AE
    Cancer Res; 1977 Feb; 37(2):595-8. PubMed ID: 188551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolactin binding to dissociated cells from rat mammary tumors and mammary gland.
    Smith RD; Hilf R; Senior AE
    Cancer Biochem Biophys; 1979; 3(3):117-21. PubMed ID: 121922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of estrogen-binding capacity by insulin in 7,12-dimethylbenz(a)anthracene-induced mammary tumors in rats.
    Gibson SL; Hilf R
    Cancer Res; 1980 Jul; 40(7):2343-8. PubMed ID: 6770998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolactin receptors in 7,12-dimethylbenz(a) anthracene-induced mammary tumors following endocrine ablation.
    Costlow ME; Buschow RA; McGuire WL
    Cancer Res; 1976 Nov; 36(11 Pt 1):3941-3. PubMed ID: 184919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth factor binding to 7,12-dimethylbenz(a)anthracene-induced mammary tumors from rats subject to chronic caloric restriction.
    Ruggeri BA; Klurfeld DM; Kritchevsky D; Furlanetto RW
    Cancer Res; 1989 Aug; 49(15):4135-41. PubMed ID: 2501022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between insulin and estrogen binding to growth response in 7,12-dimethylbenz(a)anthracene-induced rat mammary tumors.
    Shafie SM; Hilf R
    Cancer Res; 1978 Mar; 38(3):759-64. PubMed ID: 414834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of high hoses of estrogen on prolactin-binding activity and growth of carcinogen-induced mammary cancers in rats.
    Kledzik GS; Bradley CJ; Marshall S; Campbell GA; Meites J
    Cancer Res; 1976 Sep; 36(9 pt.1):3265-8. PubMed ID: 824050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolactin receptors and androgen-induced regression of 7,12-dimethylbenz(a)anthracene-induced mammary carcinoma.
    Costlow ME; Buschow RA; McGuire WL
    Cancer Res; 1976 Sep; 36(9 pt.1):3324-9. PubMed ID: 184948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of hormonal alteration of host on estrogen-binding capacity in 7,12-dimethylbenz(a)anthracene-induced mammary tumors.
    Gibson SL; Hilf R
    Cancer Res; 1976 Oct; 36(10):3736-41. PubMed ID: 133755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of host hormonal status on binding of activated estrogen receptor to nuclei from R3230AC and 7,12-dimethylbenz[a]anthracene-induced mammary tumors.
    Klinge CM; Bambara RA; Zain S; Hilf R
    Cancer Res; 1989 Mar; 49(5):1165-70. PubMed ID: 2492902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between hormone binding and growth response of rat mammary tumor.
    Holdaway IM; Friesen HG
    Cancer Res; 1976 May; 36(5):1562-7. PubMed ID: 817797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predominant role of prolactin in stimulating the growth of 7, 12-dimethylbenz(a)anthracene-induced rat mammary tumor.
    Manni A; Trujillo JE; Pearson OH
    Cancer Res; 1977 Apr; 37(4):1216-9. PubMed ID: 191182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolactin binding in ovariectomy-responsive and ovariectomy-nonresponsive rat mammary carcinoma.
    Powell BL; Diamond EJ; Koprak S; Hollander VP
    Cancer Res; 1977 May; 37(5):1328-32. PubMed ID: 15719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High inhibitory activity of a new antiestrogen, RU 16117 (11alpha-methoxy ethinyl estradiol), on the development of dimethylbenz(a)anthracene-induced mammary tumors.
    Kelly PA; Asselin J; Caron MG; Raynaud JP; Labrie F
    Cancer Res; 1977 Jan; 37(1):76-81. PubMed ID: 187338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of prolactin and growth hormone on rat mammary tumors induced by N-nitrosomethylurea.
    Rose DP; Noonan JJ
    Cancer Res; 1982 Jan; 42(1):35-8. PubMed ID: 6797725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolation and characterization of casein-producing and -nonproducing cell populations from 7,12-dimethylbenz(a)anthracene-induced rat mammary carcinomas.
    Johnson ML; Levy J; Rosen JM
    Cancer Res; 1983 May; 43(5):2199-209. PubMed ID: 6187446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Melatonin inhibition and pinealectomy enhancement of 7,12-dimethylbenz(a)anthracene-induced mammary tumors in the rat.
    Tamarkin L; Cohen M; Roselle D; Reichert C; Lippman M; Chabner B
    Cancer Res; 1981 Nov; 41(11 Pt 1):4432-6. PubMed ID: 6796259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estrogen-prolactin dependency in 7,12-dimethylbenz(a)anthracene-induced tumors.
    Leung BS; Sasaki GH; Leung JS
    Cancer Res; 1975 Mar; 35(3):621-7. PubMed ID: 163687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.